We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
2,359 hedge funds and large institutions have $104B invested in Bristol-Myers Squibb in 2020 Q4 according to their latest regulatory filings, with 286 funds opening new positions, 949 increasing their positions, 869 reducing their positions, and 108 closing their positions.
New
Increased
Maintained
Reduced
Closed
165% more first-time investments, than exits
New positions opened: 286 | Existing positions closed: 108
7% more funds holding
Funds holding: 2,214 → 2,359 (+145)
10% more call options, than puts
Call options by funds: $1.51B | Put options by funds: $1.38B
9% more repeat investments, than reductions
Existing positions increased: 949 | Existing positions reduced: 869
4% more capital invested
Capital invested by funds: $100B → $104B (+$3.72B)
0.37% less ownership
Funds ownership: 74.06% → 73.69% (-0.37%)
16% less funds holding in top 10
Funds holding in top 10: 93 → 78 (-15)
Holders
2,359
Holders Change
+145
Holders Change %
+6.55%
% of All Funds
41.74%
Holding in Top 10
78
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-16.13%
% of All Funds
1.38%
New
286
Increased
949
Reduced
869
Closed
108
Calls
$1.51B
Puts
$1.38B
Net Calls
+$132M
Net Calls Change
+$259M
Top Buyers
| 1 |
BlackRock
New York
|
+$618M |
| 2 |
JP Morgan Chase
New York
|
+$368M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$311M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$239M |
| 5 |
Morgan Stanley
New York
|
+$237M |
